BioNeutra Global Corporation Becomes a Member of the 8020 Community

EDMONTON, AL / ACCESSWIRE / October 2, 2017 / BioNeutra Global Corporation (the “Company” or “BioNeutra”) (TSX-V: BGA) is pleased to announce that it recently became a member of the 8020 Connect community. 8020 Connect (www.8020connect.com) is the investment industry’s newest investor community, developed to deliver corporate information to shareholders, investment industry experts, and like-minded investors while enabling these group members to interact with one another and with the company’s corporate management team.

Through the 8020 Connect shareholder and investor platform, BioNeutra can communicate its corporate message and update advancements and financial information to all shareholders and investors in a timely and effective fashion. 8020 Connect provides a monitored and professional environment, allowing the company to respond to questions and manage group conversations. The 8020 Connect platform and services will also provide BioNeutra with an opportunity to expand its audience to other interested investors and industry experts worldwide.

Looking for a new way to be informed? Join our Investor Group on 8020Connect.

About BioNuetra

BioNeutra is in the business of research and development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on VitaFiber™ IMOs.

The Company’s lead product, VitaFiber™, is an advanced functional and health food and beverage ingredient scientifically made from natural agricultural products, is generally regarded as safe (GRAS) by the U.S. Food & Drug Administration, and is European Food Safety Authority and Health Canada approved as a novel food ingredient. VitaFiber™ is naturally sweet and low in calories and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health.

The Company produces VitaFiber™ using its patented processes that naturally transform starch molecules from agriculture cereal crops including corn, wheat, barley, potato, or tapioca into the functional health molecules of VitaFiber™ IMO. The VitaFiber™ manufacturing process is based on a natural enzymatic conversion of starch molecules without any chemical modification involved, making VitaFiber™ a natural food and beverage ingredient. VitaFiber™ is also non-GMO, vegan-friendly, gluten-free, Kosher and Halal certified and available as certified organic.

The Company’s customers include a mix of small and medium enterprises and a number of high-profile food and beverage manufacturers in Canada, the U.S., Europe, the United Kingdom, and Mexico. VitaFiber™ is also available for retail purchase across the globe through Amazon.com and other direct-to-consumer retailers.

Mr. Bill Smith
Chairman & Senior Vice President
Tel: (780) 466-1481 (Ext. 117)
Email: bsmith@bioneutra.ca

About 8020 Connect

8020 Connect is a social and interactive investment community which expands the way shareholders and interested investors access and gather information from public corporations. Built as a hybrid social media and shareholder and management engagement platform, corporations can direct the flow of information to prospective and existing investors through both static and dynamic content. This will allow public companies to build their investment brand and investor awareness while maintaining digital media compliance in a growing online investment community.

Cautionary Statement Regarding “Forward-Looking” Information

Some of the statements contained in this news release are forward-looking statements and information within the meaning of applicable securities laws. Forward-looking statements and information can be identified by the use of words such as “expects,” “intends,” “is expected,” “potential,” “suggests” or variations of such words or phrases, or statements that certain actions, events or results “may,” “could,” “should,” “would,” “might” or “will” be taken, occur or be achieved. Forward-looking statements and information are not historical facts and are subject to a number of risks and uncertainties beyond the Company’s control. Actual results and developments are likely to differ and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by law.

Neither TSX Venture Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

SOURCE: BioNeutra Global Corporation

ReleaseID: 476813